Follow
Afsar Ali Mian
Afsar Ali Mian
Verified email at aku.edu - Homepage
Title
Cited by
Cited by
Year
CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells
M Legut, G Dolton, AA Mian, OG Ottmann, AK Sewell
Blood, The Journal of the American Society of Hematology 131 (3), 311-322, 2018
2162018
PF-114, a potent and selective inhibitor of native and mutated BCR/ABL is active against Philadelphia chromosome-positive (Ph+) leukemias harboring the T315I mutation
AA Mian, A Rafiei, I Haberbosch, A Zeifman, I Titov, V Stroylov, ...
Leukemia 29 (5), 1104-1114, 2015
642015
Targeting of the N‐terminal coiled coil oligomerization interface by a helix‐2 peptide inhibits unmutated and imatinib‐resistant BCR/ABL
T Beissert, A Hundertmark, V Kaburova, L Travaglini, AA Mian, C Nervi, ...
International journal of cancer 122 (12), 2744-2752, 2008
582008
The gatekeeper mutation T315I confers resistance against small molecules by increasing or restoring the ABL-kinase activity accompanied by aberrant transphosphorylation of …
AA Mian, M Schüll, Z Zhao, C Oancea, A Hundertmark, T Beissert, ...
Leukemia 23 (9), 1614-1621, 2009
522009
Oligomerization inhibition, combined with allosteric inhibition, abrogates the transformation potential of T315I-positive BCR/ABL
AA Mian, C Oancea, Z Zhao, OG Ottmann, M Ruthardt
Leukemia 23 (12), 2242-2247, 2009
382009
Linkage Group-Chromosome Correlation in a Mosquito: Inversions in Culex tritaeniorhynchus
RH BAKER, RK SAKAI, A MIAN
Journal of heredity 62 (1), 31-36, 1971
321971
Linkage group-chromosome correlation in a mosquito. Translocations in Culex tritaeniorhynchus.
RK Sakai, RH Baker, A Mian
311971
Overcoming Bcr-Abl T315I mutation by combination of GNF-2 and ATP competitors in an Abl-independent mechanism
M Khateb, N Ruimi, H Khamisie, Y Najajreh, A Mian, A Metodieva, ...
BMC cancer 12, 1-10, 2012
282012
Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
AA Mian, A Metodieva, S Badura, M Khateb, N Ruimi, Y Najajreh, ...
BMC cancer 12, 1-8, 2012
282012
Linkage group-chromosome correlation in Culex tritaeniorhynchus
RH Baker, RK Sakai, A Mian
Science 171 (3971), 585-587, 1971
221971
The functional interplay between the t (9; 22)-associated fusion proteins BCR/ABL and ABL/BCR in Philadelphia chromosome-positive acute lymphatic leukemia
A Rafiei, AA Mian, C Doering, A Metodieva, C Oancea, FB Thalheimer, ...
PLoS genetics 11 (4), e1005144, 2015
202015
STAT activation status differentiates leukemogenic from non-leukemogenic stem cells in AML and is suppressed by arsenic in t (6; 9)-positive AML
C Oancea, B Rüster, B Brill, J Roos, M Heinssmann, G Bug, AA Mian, ...
Genes & cancer 5 (11-12), 378, 2014
192014
Seroprevalence of cytomegalovirus, herpes simplex virus and rubella virus among pregnant women in KPK province of Pakistan
S Ali, FA Khan, AA Mian, MS Afzal
The Journal of Infection in Developing Countries 8 (03), 389-390, 2014
142014
p185BCR/ABL has a lower sensitivity than p210BCR/ABL to the allosteric inhibitor GNF-2 in Philadelphia chromosome-positive acute lymphatic leukemia
AA Mian, A Metodieva, Y Najajreh, OG Ottmann, J Mahajna, M Ruthardt
haematologica 97 (2), 251, 2012
142012
The phosphatase UBASH3B/Sts-1 is a negative regulator of Bcr-Abl kinase activity and leukemogenesis
AA Mian, I Baumann, M Liebermann, F Grebien, G Superti-Furga, ...
Leukemia 33 (9), 2319-2323, 2019
132019
Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1T315I …
AA Mian, I Haberbosch, H Khamaisie, A Agbarya, L Pietsch, E Eshel, ...
Annals of hematology 100 (8), 2023-2029, 2021
102021
STERILITY ENHANCEMENT IN THE MOSQUITO, CULEX TRITAENIORHYNCHUS
RK Sakai, RH Baker, A Mian, S Said
Canadian journal of Genetics and Cytology 14 (2), 215-220, 1972
81972
BCR: a new target in resistance mediated by BCR/ABL-315I?
I Haberbosch, A Rafiei, C Oancea, GO Ottmann, M Ruthardt, AA Mian
Genes & cancer 7 (1-2), 36, 2016
62016
PF-114, a novel selective Pan BCR/ABL inhibitor targets the T315I and suppress models of advanced Ph+ ALL
A Mian, A Rafiei, A Metodieva, I Haberbosch, A Zeifman, I Titov, V Stroylov, ...
Blood 122 (21), 3907, 2013
52013
Subtractive interaction proteomics reveal a network of signaling pathways activated by an oncogenic transcription factor in acute myeloid leukemia
N Guillen, M Wieske, A Otto, AA Mian, M Rokicki, C Guy, C Alvares, ...
BioRxiv, 464958, 2018
42018
The system can't perform the operation now. Try again later.
Articles 1–20